A growing body of research suggests that exposure to PFAS, commonly called "forever chemicals," may increase a person's risk ...

The FDA has said it cannot approve tabelecleucel to treat patients 2 years of age and older who have EBV-positive PTLD and have received at least 1 prior therapy.

The decline in cancer incidence among men and increase among women has narrowed the male‐to-female cancer incidence rate ratio from a peak of 1.6 in 1992 to 1.1 in 2021. In people aged 50-64 years, ...

More than 2 million new cases of cancer will be diagnosed in the US this year, and more than 600,000 people will die of cancer, researchers project.

Updated results from the KATHERINE trial showed that adjuvant T-DM1 provided a significant improvement in overall survival and no evidence of long-term safety issues.

Per- and polyfluoroalkyl substances (PFAS) in drinking water is associated with cancer incidence, a new study suggests.

(HealthDay News) — The US Centers for Disease Control and Prevention (CDC) recently confirmed another case of avian influenza A (H5N1), or bird flu, in a person in California, bringing the nationwide ...

The FDA has approved Calquence (acalabrutinib) for use in combination with bendamustine and rituximab to treat adults with previously untreated MCL who are ineligible for transplant.

Hormone therapy does not appear to increase the risk of glioma among women in the United States, data suggest.

Monica M. Bertagnolli, MD, has decided to resign her post as director of the NIH just 14 months after she took the position.

The FDA has revoked the authorization for the use of FD&C Red No. 3 in food and ingested drugs due to evidence suggesting this dye can cause cancer in rats.

The ASIR (per 100,000 person-years) of testicular germ cell tumors increased from 4.71 in 1992 to 6.22 in 2021, for an average annual percent change (AAPC) of 0.92%. The ASIR of seminoma increased ...